-The Times of India It was the sheer need for a livelihood that Ram Lal joined his elder brother Hakla in working at an asbestos mine at Netaji Ki Bara in Udaipur as a 12-year-old kid. Now at 34 years, Ram Lal suffers from acute respiratory problems and has been loosing weight constantly not to mention that his body is a skeleton, literally. His elder brother Hakla died in March this...
More »SEARCH RESULT
High food price, a crisis on our plate by Brinda Jagirdar
To control inflation and ensure long-term economic growth, India needs to harness the creativity of the large number of its farmers and entrepreneurs, especially in rural areas. The latest WPI inflation data show primary articles inflation in double digit, driven mainly by food inflation which remains stubbornly high at over 9 per cent. The high food prices are the result of structural factors with shortages getting aggravated as demand continues to outstrip...
More »Dantewada's dilemma by Smita Gupta
The tribal people of Chhattisgarh are in an extremely dangerous situation, caught as they are between the state forces and the Maoists. THIRTY-SIX-YEAR-OLD Soni Sori, an Adivasi schoolteacher from Chhattisgarh, was arrested in Delhi on October 4 on charges of acting as a conduit between the Essar group and the Maoists, the former accused of giving “protection money” to the latter. On October 7, she moved the Delhi High Court to...
More »EU stamp for Darjeeling Tea by Vivek Chhetri
The European Commission has registered Darjeeling Tea as a Protected Geographic Indication (PGI) product — the first commodity from India to get such a tag. The status implies that the brew produced only in Darjeeling can be sold as Darjeeling Tea in the European Union countries. But a section of blenders, who at present pass off brew with a certain percentage of Darjeeling brew as Darjeeling Tea, have been given a...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »